Current indications for transurethral resection of the prostate and associated complications
- PMID: 12751597
- PMCID: PMC11917621
- DOI: 10.1016/S1607-551X(09)70448-6
Current indications for transurethral resection of the prostate and associated complications
Abstract
Transurethral resection of the prostate (TURP) is the most common surgical procedure for relieving symptoms of benign prostatic hyperplasia. Here, we report our experience of current indications for TURP and their associated outcomes at Kaohsiung Medical University Hospital (KMUH). A total of 111 patients who underwent TURP at KMUH between May 2000 and December 2001 were included in this retrospective review. For each patient, the surgical indication was categorized into acute urinary retention, chronic complications (including renal impairment, recurrent urinary infection, bladder stone/diverticulum, post-void residue, and recurrent hematuria), and symptomatic prostatism. Thirty-five patients (31%) had acute urinary retention, 28 (27%) had chronic complications, and 48 (42%) had symptomatic prostatism. Most patients chose TURP only when medical treatment had failed to relieve symptoms, no matter what category they belonged to. Patients with acute urinary retention and chronic complications had larger prostates (p = 0.002) and more tissue resected (p = 0.05) than those with symptomatic prostatism. Patients with acute urinary retention seemed to be at greater risk of postoperative complications such as recurrent urinary retention and urinary tract infection. We suggest that urodynamic study may be necessary to rule out concomitant bladder dysfunction before surgery and that adequate prophylactic antibiotic treatment be used to decrease the risk of urinary tract infection during or after TURP, especially when pyuria is noted preoperatively in patients with acute urinary retention.
Similar articles
-
Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT.Health Technol Assess. 2020 Sep;24(41):1-96. doi: 10.3310/hta24410. Health Technol Assess. 2020. PMID: 32901611 Free PMC article. Clinical Trial.
-
The changing practice of transurethral resection of the prostate.Ann R Coll Surg Engl. 2018 Apr;100(4):326-329. doi: 10.1308/rcsann.2018.0054. Epub 2018 Mar 15. Ann R Coll Surg Engl. 2018. PMID: 29543050 Free PMC article.
-
Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.BJU Int. 2008 Nov;102(10):1432-8; discussion 1438-9. doi: 10.1111/j.1464-410X.2008.07905.x. Epub 2008 Jul 29. BJU Int. 2008. PMID: 18671785
-
Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate.Curr Urol Rep. 2018 Aug 20;19(10):85. doi: 10.1007/s11934-018-0838-4. Curr Urol Rep. 2018. PMID: 30128964 Review.
-
Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes.BJU Int. 2012 Dec;110(11):1595-601. doi: 10.1111/j.1464-410X.2012.11119.x. Epub 2012 Apr 30. BJU Int. 2012. PMID: 22540956 Review.
Cited by
-
A nomogram predicting re-operation due to secondary hemorrhage after monopolar transurethral resection of prostate.Kaohsiung J Med Sci. 2018 Mar;34(3):172-178. doi: 10.1016/j.kjms.2017.08.008. Epub 2017 Sep 29. Kaohsiung J Med Sci. 2018. PMID: 29475465 Free PMC article.
-
Prostate Tissue-Induced Platelet Activation and Platelet-Neutrophil Aggregation Following Transurethral Resection of the Prostate Surgery: An In Vitro Study.Biomedicines. 2025 Apr 21;13(4):1006. doi: 10.3390/biomedicines13041006. Biomedicines. 2025. PMID: 40299686 Free PMC article.
-
Assessment of Complications of Transurethral Resection of the Prostate Using Clavien-Dindo Classification in South Eastern Nigeria.Niger J Surg. 2020 Jul-Dec;26(2):142-146. doi: 10.4103/njs.NJS_20_20. Epub 2020 Jul 27. Niger J Surg. 2020. PMID: 33223813 Free PMC article.
-
Correlation of benign prostatic obstruction-related complications with clinical outcomes in patients after transurethral resection of the prostate.Kaohsiung J Med Sci. 2017 Mar;33(3):144-151. doi: 10.1016/j.kjms.2017.01.002. Epub 2017 Feb 13. Kaohsiung J Med Sci. 2017. PMID: 28254117 Free PMC article.
-
TRANSURETHRAL RESECTION OF THE PROSTATE IN COMMUNITY OUTREACH: WHAT ARE THE LESSONS?Ann Ib Postgrad Med. 2024 Aug 30;22(2):26-30. Ann Ib Postgrad Med. 2024. PMID: 40007709 Free PMC article.
References
-
- Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population‐based survey of urinary symptoms. J Urol. 1993; 150: 85–89. - PubMed
-
- Borth CS, Beiko DT, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: a decade of change. Urology. 2001; 57: 1082–1086. - PubMed
-
- Nickel JC. Long‐term implications of medical therapy on benign prostatic hyperplasia end points. Urology. 1998; 51 (Suppl 4A): 50–57. - PubMed
-
- Wasson JH, Bubolz TA, Lu‐Yao GL, et al. Transurethral resection of the prostate among Medicare beneficiaries: 1984 to 1997. J Urol. 2000; 164: 1212–1215. - PubMed
-
- Flanigan RC, Reda DJ, Wasson JH, et al. 5‐year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol. 1998; 160: 12–17. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical